GLIOMAS
Clinical trials for GLIOMAS explained in plain language.
Never miss a new study
Get alerted when new GLIOMAS trials appear
Sign up with your email to follow new studies for GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI steps in: new system aims to spot brain tumors more accurately, reduce risky biopsies
Diagnosis Recruiting nowThis study is developing an artificial intelligence (AI) system to help doctors analyze MRI scans and identify different types of malignant brain tumors. It will use data from 3000 adults with confirmed brain tumors to train the AI. The goal is to create a tool that makes non-inv…
Matched conditions: GLIOMAS
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 13, 2026 15:06 UTC
-
Scientists test if new drug can penetrate the Brain's defenses
Knowledge-focused Recruiting nowThis early-phase study aims to find out if the experimental drug ulixertinib can cross the blood-brain barrier and reach recurrent brain tumors called gliomas. It will enroll about 40 adults and teenagers (12+) whose tumors have a specific genetic change (MAPK-activated). The mai…
Matched conditions: GLIOMAS
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
AI tool races against time to find brain cancer treatments
Knowledge-focused Recruiting nowThis study is testing a new technology called SmartMatch that analyzes small pieces of surgically removed brain tumor tissue to see how they react to different drugs. Researchers want to see if this analysis can be completed and a report provided to doctors within 21 days of surg…
Matched conditions: GLIOMAS
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC